Global Cardiac Remote Patient Monitoring Device Market - Restraint
As per stated in AHA Journals, complications can be seen frequently as the indications of CIEDs (Cardiovascular implantable electronic devices) increases. The general trend for increase in CIED infection is been noticed, because with the associated comorbidities people live longer.
The device infection rates ranges from 2% to 8%, as per the several observational studies. Moreover, the implantable cardioverter defibrillators have the higher rate of infection.
Global Cardiac Remote Patient Monitoring Device Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China.
In 83 participating centers, the use of remote monitoring has been increased due to COVID 19 pandemic. The rate of participating centers located in other regions was similar to the regions in which the use of remote monitoring was higher due to COVID-19 cases. The number of cardiovascular implantable electronic device patients followed up by remote monitoring increased from 15% to 30% in 2021. The difference in the centers situated for higher incidence of COVID-19 cases was not found as compared to the other centers. About 33% of the participating centers reported no increase in utilization of remote monitoring as a result of COVID-19 pandemic.
Organizational issues and personnel shortage, lack of perception of the need, were the most frequent reasons for less increase in number of patients followed up by remote monitoring.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients